Farallon Capital Management »

Vaxcyte shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $22M 290k 75.51
2024-03-31 $26M 377k 68.31

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
UnitedHealth (UNH)
salesforce (CRM)
Iqvia Holdings (IQV)
Exelixis (EXEL)
Aramark Hldgs (ARMK)
Aon Shs Cl A (AON)
Microsoft Corporation (MSFT)
New York Times Cl A (NYT)
Natera (NTRA)
Ishares Tr Ishares Biotech Put Option (IBB)
Nasdaq Omx (NDAQ)
Transunion (TRU)
Intuit (INTU)

View all positions for Farallon Capital Management

Top funds holding Vaxcyte

BlackRock
BlackRock
Vanguard Group
Henderson Group
RA Capital Management
Capital Research Global Investors
T. Rowe Price Associates
T. Rowe Price Investment Management
State Street Corporation
Franklin Resources
Geode Capital Management
Darwin Global Management
Perceptive Advisors
Westfield Capital Management Company
Alliancebernstein

View all funds holding Vaxcyte